Twist Bioscience Corp financial data

Symbol
TWST on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
681 Gateway Blvd., South San Francisco, California
State of incorporation
Delaware
Fiscal year end
September 30
Latest financial report
Q1 2024 - May 2, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 585 % -11.8%
Quick Ratio 46.5 % -5.45%
Debt-to-equity 24.3 % +15.5%
Return On Equity -31.6 % -13.7%
Return On Assets -25.4 % -10.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 58.2 M shares +1.89%
Common Stock, Shares, Outstanding 58.2 M shares +1.85%
Entity Public Float 833 M USD -65.1%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 57.8 M shares +1.77%
Weighted Average Number of Shares Outstanding, Diluted 57.8 M shares +1.77%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue 171 M USD +28.1%
Research and Development Expense 95.5 M USD -23.6%
Costs and Expenses 484 M USD +7.1%
Operating Income (Loss) -207 M USD +7.82%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -191 M USD +9.66%
Income Tax Expense (Benefit) 865 K USD -3.35%
Net Income (Loss) Attributable to Parent -192 M USD +9.63%
Earnings Per Share, Basic -3.36 USD/shares +11.1%
Earnings Per Share, Diluted -3.36 USD/shares +11.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 243 M USD -22.8%
Cash, Cash Equivalents, and Short-term Investments 293 M USD -24.3%
Accounts Receivable, after Allowance for Credit Loss, Current 36 M USD -25.3%
Inventory, Net 30.4 M USD -23.9%
Assets, Current 372 M USD -24%
Property, Plant and Equipment, Net 121 M USD -17.2%
Operating Lease, Right-of-Use Asset 63.7 M USD -9.91%
Goodwill 85.8 M USD 0%
Other Assets, Noncurrent 5.4 M USD +145%
Assets 703 M USD -17.7%
Accounts Payable, Current 7.7 M USD -41.8%
Employee-related Liabilities, Current 25.2 M USD +3.85%
Accrued Liabilities, Current 14.5 M USD +30.1%
Liabilities, Current 67.5 M USD -6.4%
Operating Lease, Liability, Noncurrent 74.8 M USD -3.88%
Other Liabilities, Noncurrent 421 K USD +602%
Liabilities 143 M USD -4.85%
Accumulated Other Comprehensive Income (Loss), Net of Tax -660 K USD -695%
Retained Earnings (Accumulated Deficit) -1.12 B USD -20.7%
Stockholders' Equity Attributable to Parent 560 M USD -20.4%
Liabilities and Equity 703 M USD -17.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -23 M USD +57.5%
Net Cash Provided by (Used in) Financing Activities -1.47 M USD -273%
Net Cash Provided by (Used in) Investing Activities 4.17 M USD
Common Stock, Shares Authorized 100 M shares 0%
Common Stock, Shares, Issued 58.2 M shares +1.85%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -20.2 M USD +67%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 246 M USD -22.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 302 M USD +25.6%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 334 M USD +21.9%
Operating Lease, Liability 89.4 M USD -1.97%
Depreciation 7 M USD +22.8%
Payments to Acquire Property, Plant, and Equipment 1.51 M USD -87.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -190 M USD +11.4%
Lessee, Operating Lease, Liability, to be Paid 141 M USD -3.88%
Property, Plant and Equipment, Gross 186 M USD -1.09%
Operating Lease, Liability, Current 14.6 M USD +9.15%
Lessee, Operating Lease, Liability, to be Paid, Year Two 13.9 M USD -1.29%
Lessee, Operating Lease, Liability, to be Paid, Year One 14.8 M USD +4.37%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 51.5 M USD -7.04%
Lessee, Operating Lease, Liability, to be Paid, Year Three 8.37 M USD -33.6%
Deferred Tax Assets, Operating Loss Carryforwards 209 M USD +9.41%
Deferred Federal Income Tax Expense (Benefit) 0 USD
Current Income Tax Expense (Benefit) 1.15 M USD +50.4%
Unrecognized Tax Benefits 19.2 M USD +43.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.47 M USD +16.6%
Operating Lease, Payments 14.3 M USD -1.38%
Additional Paid in Capital 1.68 B USD +3.02%
Current State and Local Tax Expense (Benefit) 9 K USD
Current Federal Tax Expense (Benefit) 0 USD
Amortization of Intangible Assets 5.2 M USD -3.7%
Depreciation, Depletion and Amortization 8.17 M USD +54.4%
Deferred Tax Assets, Net of Valuation Allowance 31.9 M USD -5.02%
Share-based Payment Arrangement, Expense 47.2 M USD +1.34%
Deferred State and Local Income Tax Expense (Benefit) 0 USD
Interest Expense 2 K USD -92.9%